Patten Group, Inc. Vertex Pharmaceuticals Inc Transaction History

Patten Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$163.73 - $194.7 $10,969 - $13,044	-67 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$151.91 - $192.21 $2,582 - $3,267	17 Added 34.0%	67 $11,000
Q3 2017 Dec 13, 2017	BUY	$148.13 - $162.24 $7,258 - $7,949	49 Added 4900.0%	50 $8,000
Q3 2017 Nov 14, 2017	SELL	$148.13 - $162.24 $7,258 - $7,949	-49 Reduced 98.0%	1 $8,000
Q2 2017 Aug 14, 2017	BUY	N/A	50	50 $8,000

1,718

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $108B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Patten Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Patten Group, Inc. with notifications on news.